OSSIO Stock

ossio.ioHealthcare / BioTech & PharmaFounded: 2014

OSSIO is a healthcare company that provides orthopedic fixation implants that encourage natural bone healing, more safe and efficient than traditional hardware procedures. OSSIO’s proprietary, natural fiber material is implanted under the skin and around the bone area to produce a biologically friendly way to restore patient stability and mobility, with nothing permanent left behind.

Register for Details

For more details on financing and valuation for OSSIO, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for OSSIO.

Register Today

OSSIO investors also invested in these private companies

Team

Management Team

Brian Verrier
Chief Executive Officer
Orahn Preiss-Bloom
Founder & Chief Innovation Officer
Brennan Marilla
Chief Commercial Officer & Operating Officer
Moshe Shneor, CPA, MBA
Chief Financial Officer

Board Members

Udi Gilboa
Top Notch Capital
Zohar Loshitzer
Independent Director
Gary J. Pruden
Independent Director
Sanket S. Parekh
Pedilite USA
Shmulik Zysman
ZAG-S&W
Kerry Assil, MD
Independent Director
Martin J. Madden
Independent Advisor

Other companies like OSSIO in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B

News Highlights

OSSIO Closes Series C Financing of $38.5 Million
Proceeds will be used to strengthen awareness for the patient benefits of bio-integrative OSSIOfiber® implants and accelerate new product platforms into the major orthopedic fixation markets.
Updated on: Oct 1, 2023